Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Study reveals replication sites of emerging pig disease
Research could be used in the development of vaccines.

Confirms structures are similar to those in same virus family

The sites within the cell where porcine deltacoronavirus (PDCoV) makes new copies of itself during replication have been uncovered, in a study carried out at The Pirbright Institute.

According to a statement, the research confirmed that PDCoV uses the host cell’s machinery to create two different structures that form the replication organelle. These structures are very similar to those created by infectious bronchitis virus (IBV), a Gammacoronavirus that causes debilitating disease in chickens.

Using electron microscopy, Pirbright researchers where able to confirm their prediction that the structures formed by PDCoV when replicating would be comparable to those formed in replication sites in the other three genera of the coronavirus family – which have already been well defined.

This evidence suggests that there are further similarities across the family which could be targeted and used in the development of vaccines, antivirals and coronavirus resistance breeding programmes.

Head of Pirbright’s nidovirus-cell interactions group Dr Helena Maier said: “Imaging porcine deltacoronavirus during host cell infection provides an important insight into the replication mechanisms used by this group of viruses.

“This is particularly important since other Deltacoronaviruses cannot be adapted to cell culture, which makes it very challenging to study how they replicate and interact with the host cellular machinery.”

This study will inform the group’s further work in understanding how the coronavirus family interacts with host cells, and could lead to the development of broad-spectrum control methods to tackle the diseases caused by this virus family.

 

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.